Figure S7 page3 from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer

Figure S7 page3 from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer

<p>Figure S7 page3</p>

में बचाया:

ग्रंथसूची विवरण
मुख्य लेखक:	Craig M. Goodwin (14955973) (author)
अन्य लेखक:	Andrew M. Waters (14953065) (author), Jennifer E. Klomp (14961282) (author), Sehrish Javaid (14961285) (author), Kirsten L. Bryant (14955976) (author), Clint A. Stalnecker (14955952) (author), Kristina Drizyte-Miller (14961288) (author), Bjoern Papke (14961291) (author), Runying Yang (14961294) (author), Amber M. Amparo (14961297) (author), Irem Ozkan-Dagliyan (14961300) (author), Elisa Baldelli (14961303) (author), Valerie Calvert (14961306) (author), Mariaelena Pierobon (14961309) (author), Jessica A. Sorrentino (14961312) (author), Andrew P. Beelen (14961315) (author), Natalie Bublitz (14961318) (author), Mareen Lüthen (14961321) (author), Kris C. Wood (14961324) (author), Emanuel F. Petricoin (14961327) (author), Christine Sers (12163648) (author), Autumn J. McRee (14961330) (author), Adrienne D. Cox (14953077) (author), Channing J. Der (14961333) (author)
प्रकाशित:	2025
विषय:	Cancer Cancer Biology Molecular and Cellular Biology Cell Cycle CDKs and CDK inhibitors Cell Signaling Guanine nucleotide binding proteins and effectors DNA Damage and Repair DNA damage Oncogenes & Tumor Suppressors Kras Oncogenes Rb and family
टैग:	टैग जोड़ें कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन

Figure S1 page1 from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer
द्वारा: Craig M. Goodwin (14955973)
प्रकाशित: (2025)

Figure S1 page2 from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer
द्वारा: Craig M. Goodwin (14955973)
प्रकाशित: (2025)

Figure S1 page3 from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer
द्वारा: Craig M. Goodwin (14955973)
प्रकाशित: (2025)

Figure S1 page4 from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer
द्वारा: Craig M. Goodwin (14955973)
प्रकाशित: (2025)

Figure S2 page1 from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer
द्वारा: Craig M. Goodwin (14955973)
प्रकाशित: (2025)

Figure S2 page2 from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer
द्वारा: Craig M. Goodwin (14955973)
प्रकाशित: (2025)

Figure S2 page3 from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer
द्वारा: Craig M. Goodwin (14955973)
प्रकाशित: (2025)

Figure S3 page1 from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer
द्वारा: Craig M. Goodwin (14955973)
प्रकाशित: (2025)

Figure S3 page2 from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer
द्वारा: Craig M. Goodwin (14955973)
प्रकाशित: (2025)

Figure S4 page1 from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer
द्वारा: Craig M. Goodwin (14955973)
प्रकाशित: (2025)

Figure S4 page2 from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer
द्वारा: Craig M. Goodwin (14955973)
प्रकाशित: (2025)

Figure S5 page1 from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer
द्वारा: Craig M. Goodwin (14955973)
प्रकाशित: (2025)

Figure S5 page2 from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer
द्वारा: Craig M. Goodwin (14955973)
प्रकाशित: (2025)

Figure S5 page2 from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer
द्वारा: Craig M. Goodwin (14955973)
प्रकाशित: (2025)

Figure S5 page3 from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer
द्वारा: Craig M. Goodwin (14955973)
प्रकाशित: (2025)

Figure S6 page1 from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer
द्वारा: Craig M. Goodwin (14955973)
प्रकाशित: (2025)

Figure S6 page2 from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer
द्वारा: Craig M. Goodwin (14955973)
प्रकाशित: (2025)

Figure S7 page1 from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer
द्वारा: Craig M. Goodwin (14955973)
प्रकाशित: (2025)

Figure S7 page2 from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer
द्वारा: Craig M. Goodwin (14955973)
प्रकाशित: (2025)

Supplementary Tables from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer
द्वारा: Craig M. Goodwin (14955973)
प्रकाशित: (2025)

Supplementary Table 1 from Abemaciclib Is Effective in Palbociclib-Resistant Hormone Receptor–Positive Metastatic Breast Cancers
द्वारा: Juliana Navarro-Yepes (17079059)
प्रकाशित: (2025)

Figure 1 from Cancer-Associated SF3B1 Mutations Confer a BRCA-Like Cellular Phenotype and Synthetic Lethality to PARP Inhibitors
द्वारा: Katrina M. Lappin (9340394)
प्रकाशित: (2025)

Figure 2 from Cancer-Associated SF3B1 Mutations Confer a BRCA-Like Cellular Phenotype and Synthetic Lethality to PARP Inhibitors
द्वारा: Katrina M. Lappin (9340394)
प्रकाशित: (2025)

Figure 3 from Cancer-Associated SF3B1 Mutations Confer a BRCA-Like Cellular Phenotype and Synthetic Lethality to PARP Inhibitors
द्वारा: Katrina M. Lappin (9340394)
प्रकाशित: (2025)

Figure 4 from Cancer-Associated SF3B1 Mutations Confer a BRCA-Like Cellular Phenotype and Synthetic Lethality to PARP Inhibitors
द्वारा: Katrina M. Lappin (9340394)
प्रकाशित: (2025)

Supplementary Tables S1-S11 from <i>NBN</i> Pathogenic Germline Variants are Associated with Pan-Cancer Susceptibility and <i>In Vitro</i> DNA Damage Response Defects
द्वारा: Sami Belhadj (15052341)
प्रकाशित: (2025)

Supplementary Data from SENP1 Decreases RNF168 Phase Separation to Promote DNA Damage Repair and Drug Resistance in Colon Cancer
द्वारा: Min Wei (16918572)
प्रकाशित: (2025)

Supplementary Data from SENP1 Decreases RNF168 Phase Separation to Promote DNA Damage Repair and Drug Resistance in Colon Cancer
द्वारा: Min Wei (16918572)
प्रकाशित: (2025)

Supplementary Data from FOXA2 Cooperates with Mutant KRAS to Drive Invasive Mucinous Adenocarcinoma of the Lung
द्वारा: Koichi Tomoshige (15304682)
प्रकाशित: (2025)

Supplementary Data from CRISPR/Cas9-Induced DNA Damage Enriches for Mutations in a p53-Linked Interactome: Implications for CRISPR-Based Therapies
द्वारा: Long Jiang (14956159)
प्रकाशित: (2025)

Supplementary Data from CRISPR/Cas9-Induced DNA Damage Enriches for Mutations in a p53-Linked Interactome: Implications for CRISPR-Based Therapies
द्वारा: Long Jiang (14956159)
प्रकाशित: (2025)

Supplementary Table from CRISPR/Cas9-Induced DNA Damage Enriches for Mutations in a p53-Linked Interactome: Implications for CRISPR-Based Therapies
द्वारा: Long Jiang (14956159)
प्रकाशित: (2025)

Table S1 from Breast Cancer Mutations <i>HER2<sup>V777L</sup></i> and <i>PIK3CA<sup>H1047R</sup></i> Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance
द्वारा: Xiaoqing Cheng (16918496)
प्रकाशित: (2025)

Table S2 from Breast Cancer Mutations <i>HER2<sup>V777L</sup></i> and <i>PIK3CA<sup>H1047R</sup></i> Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance
द्वारा: Xiaoqing Cheng (16918496)
प्रकाशित: (2025)

Table S3 from Breast Cancer Mutations <i>HER2<sup>V777L</sup></i> and <i>PIK3CA<sup>H1047R</sup></i> Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance
द्वारा: Xiaoqing Cheng (16918496)
प्रकाशित: (2025)

Table S4 from Breast Cancer Mutations <i>HER2<sup>V777L</sup></i> and <i>PIK3CA<sup>H1047R</sup></i> Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance
द्वारा: Xiaoqing Cheng (16918496)
प्रकाशित: (2025)

Table S5 from Breast Cancer Mutations <i>HER2<sup>V777L</sup></i> and <i>PIK3CA<sup>H1047R</sup></i> Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance
द्वारा: Xiaoqing Cheng (16918496)
प्रकाशित: (2025)

Table S6 from Breast Cancer Mutations <i>HER2<sup>V777L</sup></i> and <i>PIK3CA<sup>H1047R</sup></i> Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance
द्वारा: Xiaoqing Cheng (16918496)
प्रकाशित: (2025)

Table S1 from ENIGMA <i>CHEK2</i>gether Project: A Comprehensive Study Identifies Functionally Impaired <i>CHEK2</i> Germline Missense Variants Associated with Increased Breast Cancer Risk
द्वारा: Lenka Stolarova (16547259)
प्रकाशित: (2025)

Table S2 from ENIGMA <i>CHEK2</i>gether Project: A Comprehensive Study Identifies Functionally Impaired <i>CHEK2</i> Germline Missense Variants Associated with Increased Breast Cancer Risk
द्वारा: Lenka Stolarova (16547259)
प्रकाशित: (2025)

Cannot write session to /tmp/vufind_sessions/sess_7k42cudv4bb0992rj28vmfvli4